Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (4849)	5/10/1998 2:41:00 AM
From: aknahow	Respond to of 9719

Rocketman, another article should prove to be more important for biotechs in general. Mondays Barrons cover story on duPont. duPont outlines three ways it can grow in the Life Science area. One is acquire small biotechs. The others are acquire a large pharma and by investing its' own funds. It says it is considering all of these options. See longer post on Xoma thread for my ideas of implications. The implications apply to the entire sector, I just posted on the XOMA thread because it was there.<g>